Geron [GERN] is the name many traders talk about as a leader in stem cell research, says Pete Najarian. However, it’s important to keep in mind that major breakthroughs are probably a way out, still.

In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. Personally, my favorite stock in the space is Celgene, adds Guy Adami.

In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. - Pete Najarian

In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. - Pete Najarian

Or if you don’t want to play stock picker, you can get broad exposure with the SPDR S&P Biotech ETF[XBI]. - Pete Najarian

Or you can play the iShares NASDAQ Biotechnology Index ETF [IBB], adds Karen Finerman.